Skip to main content
Srinivas Viswanathan, MD, Oncology, Boston, MA

SrinivasR.ViswanathanMDPhD

Oncology Boston, MA

Dana Farber Cancer Institute

Dr. Viswanathan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Viswanathan's full profile

Already have an account?

  • Office

    55 Fruit St
    Wac 615
    Boston, MA 02114
    Phone+1 617-726-2674
    Fax+1 617-724-0393

Education & Training

  • Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2013 - 2017
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2011 - 2014
  • Harvard Medical School
    Harvard Medical SchoolClass of 2011
  • Yale University
    Yale UniversityB. S., M.S., 2000 - 2004

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2013 - 2026
  • NH State Medical License
    NH State Medical License 2024 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Journal Articles

  • Genome-Scale Analysis Identifies Paralog Lethality as a Vulnerability of Chromosome 1p Loss in Cancer  
    William C Hahn, Srinivas R Viswanathan, Nature

Press Mentions

  • The Male X Chromosome Is Silenced in Some Cancer Types
    The Male X Chromosome Is Silenced in Some Cancer TypesDecember 30th, 2022
  • Scientists Discover X Chromosomes Being 'Silenced' in Male Cancer Cells
    Scientists Discover X Chromosomes Being 'Silenced' in Male Cancer CellsNovember 15th, 2022